publication date: Jul 6, 2011
|
author/source: BioCentrum
BioCentrum, part of
the Selvita Group, received a certificate of compliance with the
principles of Good Laboratory Practice (GLP). The certificate was awarded
after a successfully completed verification by the Bureau for Chemical
Substances (institution of governmental administration granting GLP
certificates).
GLP Certificate No 3/2011/DPL
covers all the activities of the BioCentrum's Cell Laboratory,
including analytical and clinical chemistry testing, as well as
in vitro
tests in the area of cytotoxicity of chemical substances. This
certificate has been issued for an indefinite period of time, however its
subject to compulsory re-certification in 2 years from the date of the issue.
GLP
certification marks a very important step in the company's development. It
provides evidence that the services offered by BioCentrum are performed with
the highest quality standards and requirements set by the industry, as well as
it shows that BioCentrum possesses adequate facilities
and equipment, as well as employs a team of professionals who
guarantee the highest standards of
quality in all performed work.
"GLP Certification is
an extremely important stage in the development of our company.
This certification is an
indication that all the services and research done
by us in the field of cell and molecular biology are
conducted in accordance with the highest international
standards of Good Laboratory Practice. This certification is also a
confirmation that our standards of work in the laboratory
are identical with those of the finest laboratories in the
world. Since the very beginning of BioCentrum we've been striving to deliver
our customers with the highest quality of services,
GLP certification is a confirmation that we've been able to achieve
that, " said Dr Milosz Gruca, BioCentrum's R&D Director and
Member of the Board.
Good Laboratory Practice (GLP) embodies a set of principles that
provides a framework within which laboratory studies are planned, performed, monitored,
recorded, reported and archived. These studies are undertaken to generate data
by which the hazards and risks to users, consumers and third parties, including
the environment, can be assessed for pharmaceuticals (only preclinical
studies), agrochemicals, cosmetics, food additives, feed additives and
contaminants, novel foods, biocides, detergents etc....GLP was instituted as a
standard meant to ensure the quality, integrity, and reliability of safety
data.
About BioCentrum
BioCentrum is a privately-owned biotechnology service and product provider from
Kraków, Poland and is a part of Selvita group since 2008. The company was
established in 2004 and its mission is to create a platform for its clients and
partners in order to help them translate innovative discoveries into
preclinical candidates with improved chances to reach the market, in the
shortest amount of time possible.
BioCentrum
is active in several areas of life science and offers a following range of
services:
- In
vitro preclinical development
services, which include the key steps in the process of drug development,
used in the pharmaceutical and biopharmaceutical industry.
- In
vitro assay development, working
primarily on ELISA and cytotoxicity assays. We execute spectrophotometric,
fluorescence, fluorescence anisotrophy and chemiluminescence measurements,
as well as we perform cell cycle arrest analysis and apoptosis/necrosis
identification in the area of fluorescence analysis.
- Highly
specialized services in analytical and physicochemical chemistry, aimed at
the companies from pharmaceutical industry
- REACH
analytical services
- Services
in the field of protein chemistry, covering a wide range of standard and
advanced analysis, as well as the production and purification of proteins.
- Production
of highly purified and highly active enzymes, inhibitors and other
biologically active recombinant proteins.
The laboratory is fully integrated with STARLIMS laboratory information
management system both for control of the analytical equipment and for data
reporting and processing. Since 2010, BioCentrum's laboratory is certified with
the General Pharmaceutical Inspectorate certificate, in the field of
therapeutical substance manufacturing for the physicochemical analyses of the
substances and their certification, as well as with the GLP certificate for the
analytical and clinical chemistry testing, and
in vitro tests in the
area of cytotoxicity of chemical substances.
For further information visit
www.biocentrum.com.pl